Clinical trials

  • AZD5492 for Systemic lupus erythematosus | Rheumatoid arthritis | Idiopathic inflammatory myopathy
  • Nintedanib for Hereditary haemorrhagic telangiectasia
  • Hydroxychloroquine sulfate for Multiple sclerosis | Progressive multiple sclerosis
  • CAPECITABINE for Locally advanced rectal cancer (stage II/III)
  • NIVOLUMAB for Inflammatory bowel disease|Rheumatic disease|Cancer
  • RISANKIZUMAB for Ulcerative colitis
  • FICERAFUSP ALFA for Head and neck squamous cell carcinoma
  • venetoclax for HIV-1 infection
  • BEVACIZUMAB for Neovascular age-related macular degeneration | Age-related macular degeneration
  • MRNA-4157 for Non-small cell lung cancer (stage IV) | Squamous non-small cell lung cancer
  • SILIBININ for Cushing's disease
  • Rituximab for Systemic lupus erythematosus